Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J.J. Doyle
Pcp61 - Evidence-Based Value of Pd-1 / Pd-L1 Inhibitors in Nsclc: Comparison of Value to Price
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PHP38 Point-Of-Care Diagnostic Test Reimbursement and Market Access: Lessons From a Survey of Global Health Technology Assessments
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
MA11.06 Prognostic Value of Complement System in NSCLC and Its Association With PD-1 and PD-L1 Expression
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Immunotherapies Based on PD-1/PD-L1 Pathway Inhibitors in Ovarian Cancer Treatment
Clinical and Experimental Immunology
Allergy
Immunology
Continuous Targeted Kinase Inhibitors Treatment Induces Upregulation of PD-L1 in Resistant NSCLC
Scientific Reports
Multidisciplinary
P3.01-18 Comparison of PD-L1 Immunohistochemical Assays and Clinical Response to Anti PD-1 Checkpoint Inhibitors in Patients With Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.01-82 Neutrophil-To-Lymphocyte Ratio Complements the Prognostic Ability of PD-L1 in Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Prognostic Value, Localization and Correlation of PD-1/PD-L1, CD8 and FOXP3 With the Desmoplastic Stroma in Pancreatic Ductal Adenocarcinoma
Oncotarget
Oncology
P1.01-08 Hyperresponsive Disease: A New Pattern of Response in NSCLC Patients Treated by Anti-Pd-1/Pd-L1
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Macrophage PD-L1 Strikes Back: PD-1/PD-L1 Interaction Drives Macrophages Toward Regulatory Subsets
Advances in Bioscience and Biotechnology
Design of PD-L1 Inhibitors for Lung Cancer
Bioinformation